Whilst therapeutics focusing on the regulation of mTOR are already within clinical practice, unravelling the complex roles of miRNAs associated with mTOR pathways specific to the pathogenies of SMA may reveal novel strategies for intervention. The gene discussed is MTOR; the disease is proximal spinal muscular atrophy.